Join
Live feed
·
INSIDERFilingvia Quantisnow
Puma Biotechnology Inc logo

President and CEO Auerbach Alan H sold $364,051 worth of shares (44,058 units at $8.26) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 7,261,671 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PBYI· Puma Biotechnology Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBYI (Puma Biotechnology Inc) and more on Quantisnow.